Yasmeen Gangani, MD
Pediatrics · Morgan Hill
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- 3
- 2 carriers
- Office
- 1
On the public record
- 1 Medical Board action on record
Offices
1 location
Plans that list them
3 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Gangani’s office at (408) 778-2025 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
3 of 3 plans
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A46598 · Current
Licensed to practise in California · since 1989 · expires 2027-10-31 · University of Karachi, Dow Medical College. Board flags: Public Reprimand.
Public record actions
| 2026-07-28 | Board disciplineDiscipline | Public letter of reprimand. · 8002024110648 |
Medicaid work
$30,676 in 2024
Medicaid paid $30,676 for 1,394 billed services this clinician did in 2024, up to 42 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Developmental screening | 377 | $22,493 |
| Pure tone audiometry (threshold); air only | 217 | $3,568 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 39 | $1,789 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 42 | $1,334 |
| Screening performed and negative | 152 | $1,146 |
| Influenza virus vaccine, trivalent (ccIIV3), derived from cell cultures, subunit, antibiotic free, 0.5 mL dosage, for intramuscular use | 23 | $188 |
| Return visit (30+ min) | 159 | $82 |
| Short return visit (20+ min) | 299 | $79 |
| Face-to-face behavioral counseling for obesity, 15 minutes | 86 | $0 |
| 2024 | 1,394 | 9 | 42 | $30,676 |
| 2023 | 2,215 | 13 | 50 | $33,783 |
| 2022 | 2,503 | 15 | 61 | $16,375 |
| 2021 | 2,625 | 15 | 76 | $40,512 |
| 2020 | 1,840 | 17 | 70 | $32,586 |
| 2019 | 2,618 | 17 | 84 | $34,809 |
| 2018 | 1,502 | 16 | 54 | $18,800 |
See the largest Medicaid services in earlier years
2023
| Developmental screening | 397 | $20,911 |
| Pure tone audiometry (threshold); air only | 252 | $4,137 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 50 | $2,224 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 62 | $2,102 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 29 | $1,632 |
| Influenza virus vaccine, quadrivalent, live (LAIV4), for intranasal use | 51 | $1,107 |
| Measurement of lead | 80 | $774 |
| Screening performed and negative | 199 | $580 |
| Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, preservative and antibiotic free, 0.5 mL dosage, for intramuscular use | 52 | $317 |
| Short return visit | 15 | $0 |
| Short return visit (20+ min) | 481 | $0 |
| Return visit (30+ min) | 276 | $0 |
2022
| Developmental screening | 448 | $7,292 |
| Pure tone audiometry (threshold); air only | 264 | $3,370 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 57 | $1,731 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 38 | $1,257 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 27 | $1,028 |
| Screening performed and negative | 443 | $757 |
| DIPHTH TETANUS TOX ACELL PERTUSSIS VACC<7 YR IM | 58 | $367 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use | 29 | $288 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 39 | $238 |
| Measurement of lead | 13 | $47 |
| Annual alcohol misuse screening, 5 to 15 minutes | 53 | $0 |
| Bilateral quantitative screening test of visual acuity | 41 | $0 |
2021
| Developmental screening | 574 | $25,159 |
| Pure tone audiometry (threshold); air only | 408 | $4,827 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 68 | $3,204 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 89 | $2,900 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 70 | $2,185 |
| Screening performed and negative | 573 | $930 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 97 | $516 |
| Influenza virus vaccine, quadrivalent, live (LAIV4), for intranasal use | 25 | $415 |
| DIPHTH TETANUS TOX ACELL PERTUSSIS VACC<7 YR IM | 26 | $169 |
| Human Papillomavirus vaccine types 6, 11, 16, 18, 31, 33, 45, 52, 58, nonavalent (9vHPV), 2 or 3 dose schedule, for intramuscular use | 28 | $119 |
| Poliovirus vaccine, inactivated (IPV), for subcutaneous or intramuscular use | 13 | $89 |
| Bilateral quantitative screening test of visual acuity | 90 | $0 |
2020
| Developmental screening | 442 | $19,707 |
| Pure tone audiometry (threshold); air only | 268 | $3,266 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 99 | $2,762 |
| Influenza virus vaccine, quadrivalent, live (LAIV4), for intranasal use | 61 | $1,900 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 36 | $1,330 |
| Screening performed and negative | 265 | $1,227 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 32 | $1,015 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 60 | $427 |
| DIPHTH TETANUS TOX ACELL PERTUSSIS VACC<7 YR IM | 58 | $377 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 27 | $188 |
| Haemophilus influenzae type b vaccine (Hib), PRP-T conjugate, 4 dose schedule, for intramuscular use | 24 | $159 |
| Human Papillomavirus vaccine types 6, 11, 16, 18, 31, 33, 45, 52, 58, nonavalent (9vHPV), 2 or 3 dose schedule, for intramuscular use | 18 | $149 |
2019
| Developmental screening | 693 | $21,686 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 142 | $3,792 |
| Pure tone audiometry (threshold); air only | 387 | $3,600 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 51 | $1,511 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 41 | $956 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 148 | $853 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 39 | $822 |
| DIPHTH TETANUS TOX ACELL PERTUSSIS VACC<7 YR IM | 97 | $625 |
| Meningococcal conjugate vaccine, serogroups A, C, W, Y, quadrivalent, diphtheria toxoid carrier (MenACWY-D) or CRM197 carrier (MenACWY-CRM), for intramuscular use | 23 | $254 |
| Human Papillomavirus vaccine types 6, 11, 16, 18, 31, 33, 45, 52, 58, nonavalent (9vHPV), 2 or 3 dose schedule, for intramuscular use | 49 | $218 |
| Poliovirus vaccine, inactivated (IPV), for subcutaneous or intramuscular use | 40 | $218 |
| Return visit (30+ min) | 584 | $135 |
2018
| Developmental screening | 401 | $14,360 |
| Pure tone audiometry (threshold); air only | 100 | $1,158 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 32 | $989 |
| DIPHTH TETANUS TOX ACELL PERTUSSIS VACC<7 YR IM | 69 | $575 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 23 | $574 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 81 | $357 |
| Haemophilus influenzae type b vaccine (Hib), PRP-T conjugate, 4 dose schedule, for intramuscular use | 34 | $258 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 36 | $258 |
| Poliovirus vaccine, inactivated (IPV), for subcutaneous or intramuscular use | 15 | $139 |
| Rotavirus vaccine, pentavalent (RV5), 3 dose schedule, live, for oral use | 15 | $89 |
| Return visit (30+ min) | 361 | $43 |
| Immunization administration through 18 years of age via any route of administration, with counseling by physician or other qualified health care professional; first or only component of each vaccine or toxoid administered | 133 | $0 |
Money from drug and device companies
$17 in 2024
| 2024 | 1 | 1 | None | $17 |
| 2023 | 1 | 1 | None | $16 |
| 2022 | 1 | 1 | None | $16 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| AstraZeneca Pharmaceuticals LP | Flumist Quadrivalent | $17 | 1 payment
|
See the published payment
| AstraZeneca Pharmaceuticals LP | Meals · 2024-02-09 | Flumist Quadrivalent | $17 |
See earlier years (2023, 2022)
2023: $16
| Pfizer | Prevnar 20 | $16 | 1 payment
|
2022: $16
| Pfizer | Prevnar 13 | $16 | 1 payment
|
Professional record
- NPI
- 1992799365
- Licence
- CA A46598California A46598: Current · expires 2027-10-31
More record details
- Sole proprietor
- Yes
- Taxonomy
- Pediatrics (208000000X)
- Mailing address
- 18550 Depaul Dr, Ste 102, Morgan Hill, CA, 95037
- NPI first listed
- 2005-08-31
- NPI last updated
- 2011-09-26
This is when the NPI record was last certified, not a medical board exam.